Arnold Markoe

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. ncbi Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data
    May Abdel-Wahab
    Department of Radiation Oncology, Miller School of Medicine, University of Miami, 1475 NW 12th Ave D 31, Miami, FL 33 136, USA
    Urology 74:866-71. 2009
  2. ncbi Integrating the healthcare enterprise in radiation oncology plug and play--the future of radiation oncology?
    May Abdel-Wahab
    Department of Radiation Oncology, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA
    Int J Radiat Oncol Biol Phys 76:333-6. 2010
  3. ncbi Influence of number of CAG repeats on local control in the RTOG 86-10 protocol
    May Abdel-Wahab
    Department of Radiation Oncology, University of Miami School of Medicine, Miami, FL 33136, USA
    Am J Clin Oncol 29:14-20. 2006
  4. ncbi Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma
    May Abdel-Wahab
    Department of Radiation Oncology, University of Miami, Miami, Florida 33136, USA
    Am J Clin Oncol 28:359-66. 2005
  5. ncbi Spinal cord gliomas: A multi-institutional retrospective analysis
    May Abdel-Wahab
    Department of Radiation Oncology, University of Miami, Miami, FL, USA
    Int J Radiat Oncol Biol Phys 64:1060-71. 2006
  6. ncbi Androgen receptor antigen density and S-phase fraction in prostate cancer: a pilot study
    M Abdel-Wahab
    Department of Radiation Oncology, University of Miami, Florida 33136, USA
    Prostate Cancer Prostatic Dis 6:294-300. 2003
  7. ncbi Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy
    May Abdel-Wahab
    Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Int J Radiat Oncol Biol Phys 72:58-68. 2008
  8. ncbi Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: A-3 protocol
    Andre Abitbol
    University of Miami, Department of Radiation Oncology, Miami, Florida 33136, USA
    Am J Clin Oncol 28:449-55. 2005
  9. ncbi Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol
    Andre Abitbol
    Department of Radiation Oncology, Baptist Hospital, Miami, FL, USA
    Int J Radiat Oncol Biol Phys 53:942-7. 2002
  10. ncbi Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer
    Matthew C Biagioli
    Department of Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA
    Int J Radiat Oncol Biol Phys 69:1067-73. 2007

Collaborators

Detail Information

Publications20

  1. ncbi Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data
    May Abdel-Wahab
    Department of Radiation Oncology, Miller School of Medicine, University of Miami, 1475 NW 12th Ave D 31, Miami, FL 33 136, USA
    Urology 74:866-71. 2009
    ..To determine the incidence of second primary cancer (SPC) and primary pelvic late SPC/radiation-induced SPC after radical prostatectomy and radiation...
  2. ncbi Integrating the healthcare enterprise in radiation oncology plug and play--the future of radiation oncology?
    May Abdel-Wahab
    Department of Radiation Oncology, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA
    Int J Radiat Oncol Biol Phys 76:333-6. 2010
    ..To describe the processes and benefits of the integrating healthcare enterprises in radiation oncology (IHE-RO)...
  3. ncbi Influence of number of CAG repeats on local control in the RTOG 86-10 protocol
    May Abdel-Wahab
    Department of Radiation Oncology, University of Miami School of Medicine, Miami, FL 33136, USA
    Am J Clin Oncol 29:14-20. 2006
    ..The purpose of this study was to determine if short-term androgen deprivation therapy (RT + HT) can improve outcome in patients with tumors with short CAG repeats (<19)...
  4. ncbi Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma
    May Abdel-Wahab
    Department of Radiation Oncology, University of Miami, Miami, Florida 33136, USA
    Am J Clin Oncol 28:359-66. 2005
    ..To determine quality of life (QOL) after hyperfractionated radiation and chemotherapy...
  5. ncbi Spinal cord gliomas: A multi-institutional retrospective analysis
    May Abdel-Wahab
    Department of Radiation Oncology, University of Miami, Miami, FL, USA
    Int J Radiat Oncol Biol Phys 64:1060-71. 2006
    ..To determine the impact of postoperative radiation therapy (POXRT) on outcome in spinal cord gliomas...
  6. ncbi Androgen receptor antigen density and S-phase fraction in prostate cancer: a pilot study
    M Abdel-Wahab
    Department of Radiation Oncology, University of Miami, Florida 33136, USA
    Prostate Cancer Prostatic Dis 6:294-300. 2003
    ..To determine whether quantitative flow cytometric androgen receptor density expression (MFC ratio) in prostate cancer was associated with S-phase fraction...
  7. ncbi Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy
    May Abdel-Wahab
    Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA
    Int J Radiat Oncol Biol Phys 72:58-68. 2008
    ..To determine the incidence of second primary cancers (SPCs) and radiotherapy-induced SPCs (RTSPCs)...
  8. ncbi Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: A-3 protocol
    Andre Abitbol
    University of Miami, Department of Radiation Oncology, Miami, Florida 33136, USA
    Am J Clin Oncol 28:449-55. 2005
    ..A locoregional control benefit should be confirmed in a prospective, randomized trial. Alternative amifostine delivery methods should be investigated...
  9. ncbi Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol
    Andre Abitbol
    Department of Radiation Oncology, Baptist Hospital, Miami, FL, USA
    Int J Radiat Oncol Biol Phys 53:942-7. 2002
    ..However, although a locoregional control benefit is suggested by the preliminary results of this trial, it needs to be confirmed in a prospective randomized trial...
  10. ncbi Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer
    Matthew C Biagioli
    Department of Radiation Oncology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA
    Int J Radiat Oncol Biol Phys 69:1067-73. 2007
    ..Intensity-modulated radiotherapy (IMRT) has recently emerged as a new modality for salvage therapy. This retrospective study evaluated our experience using every-other-week IMRT with concurrent chemotherapy...
  11. ncbi Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors
    Lynn G Feun
    Sylvester Comprehensive Cancer Center, University of Miami, and VA Medical Center, Miami, FL 33136, USA
    J Neurooncol 82:177-81. 2007
    ..Myelosuppression is the main toxicity when topoisomerase I and II inhibitors are combined together...
  12. ncbi Clinical outcome of patients treated with 3D conformal radiation therapy (3D-CRT) for prostate cancer on RTOG 9406
    Jeff Michalski
    Department of Radiation Oncology, Washington University Medical School, St Louis, MO 63110, USA
    Int J Radiat Oncol Biol Phys 83:e363-70. 2012
    ..Report of clinical cancer control outcomes on Radiation Therapy Oncology Group (RTOG) 9406, a three-dimensional conformal radiation therapy (3D-CRT) dose escalation trial for localized adenocarcinoma of the prostate...
  13. ncbi Extended remission of a recurrent median nerve malignant peripheral nerve sheath tumor after multimodal treatment. Case report
    Howard Landy
    Department of Neurological Surgery, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, Florida 33136, USA
    J Neurosurg 103:760-3. 2005
    ..A review of the patient's treatment is warranted to provide a description of a regimen that may be useful in the treatment of similar patients in the future...
  14. ncbi Salvage external beam radiotherapy of retinal capillary hemangiomas secondary to von Hippel-Lindau disease: visual and anatomic outcomes
    Deepak Raja
    Department of Ophthalmology, Bascom Palmer Eye Institute University of Miami School of Medicine, Miami, Florida 33101, USA
    Ophthalmology 111:150-3. 2004
    ..External beam radiotherapy leads to improvement in visual acuity, reduction in tumor volume, and stabilization of retinal detachment in most patients treated...
  15. ncbi Pilot study of estramustine added to radiosurgery and radiotherapy for treatment of high grade glioma
    Howard Landy
    Department of Neurological Surgery, University of Miami School of Medicine, Miami 33136, USA
    J Neurooncol 67:215-20. 2004
    ..Four of the new glioblastoma patients developed deep vein thrombosis. The results of this pilot study indicate some benefit, and further investigation incorporating estramustine into clinical trials is suggested...
  16. ncbi Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy
    Daniel A Sussman
    Bascom Palmer Eye Institute, University of Miami School of Medicine, FL 33101, USA
    Arch Ophthalmol 121:979-84. 2003
    ..CONCLUSIONS: Retinoblastoma reduction exhibits a differential time course based on the applied primary treatment. Systemic chemotherapy is associated with earlier tumor reduction than EBRT...
  17. ncbi Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci
    Manuel F Rosado
    Sylvester Comprehensive Cancer Center, Division of Hematology-Oncology, Department of Medicine, University of Miami, FL 33136, USA
    Blood 107:467-72. 2006
    ..In South Florida, OALs are not associated with C psittaci infections...
  18. ncbi Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation
    Jean L Wright
    Department of Radiation Oncology, University of Miami Miller School of Medicine, Florida, USA
    Cancer 119:16-25. 2013
    ....
  19. ncbi University of Miami experience using one versus two intracavitary brachytherapy implants
    May Abdel-Wahab
    University of Miami School/Jackson Memorial Hospital, Florida, USA
    Am J Clin Oncol 25:313-7. 2002
    ..However, because of the confounding interactions of cumulative dose to point A and overall treatment time in the present series, a prospectively randomized phase III trial is needed to more adequately evaluate this question...
  20. ncbi Trade-off to low-grade toxicity with conformal radiation therapy for prostate cancer on Radiation Therapy Oncology Group 9406
    Jeff M Michalski
    Washington University Medical School, St Louis, MO 63110, USA
    Semin Radiat Oncol 12:75-80. 2002
    ..Clinical trials should use quality-of-life measures to determine that trade-offs between severity and rates of toxicity are acceptable to patients...